Fanzhen Hong1, Yuyang Li2, Yongping Xu2. 1. Department of Obstetrics and Gynaecology, The Second Hospital of Shandong University, Jinan, China dochongfz@163.com. 2. Department of Obstetrics and Gynaecology, The Second Hospital of Shandong University, Jinan, China.
Abstract
OBJECTIVES: To detect microRNA (miR)-126 expression and its correlation with vascular endothelial growth factor (VEGF) levels in placentas from patients with pre-eclampsia compared with those from normotensive pregnancies. METHODS: miR-126 expression, and VEGF mRNA and protein levels, in placentas collected sequentially from patients with pre-eclampsia and normotensive pregnancies were measured using real-time reverse transcription-polymerase chain reaction and Western blot, respectively. The relationship between miR-126 and VEGF expression was analysed statistically. The regulatory effect of miR-126 on VEGF expression in human placental choriocarcinoma (BeWo) cells in vitro was also investigated. RESULTS: miR-126 expression was decreased, and VEGF mRNA and protein levels were significantly lower, in placentas from patients with pre-eclampsia (n = 115) compared with placentas from normotensive pregnancies (n = 115). A positive correlation was found between VEGF mRNA and miR-126 expression (r = 0.79). In addition, miR-126 overexpression significantly upregulated VEGF expression in BeWo cells, whereas miR-126 downregulation decreased VEGF expression. CONCLUSIONS: miR-126 was downregulated in placentas from patients with pre-eclampsia and this correlated with decreased VEGF expression. These findings indicate that miRNA-126 may be involved in pre-eclampsia pathogenesis and could be a potential biomarker for this disease.
OBJECTIVES: To detect microRNA (miR)-126 expression and its correlation with vascular endothelial growth factor (VEGF) levels in placentas from patients with pre-eclampsia compared with those from normotensive pregnancies. METHODS:miR-126 expression, and VEGF mRNA and protein levels, in placentas collected sequentially from patients with pre-eclampsia and normotensive pregnancies were measured using real-time reverse transcription-polymerase chain reaction and Western blot, respectively. The relationship between miR-126 and VEGF expression was analysed statistically. The regulatory effect of miR-126 on VEGF expression in human placental choriocarcinoma (BeWo) cells in vitro was also investigated. RESULTS:miR-126 expression was decreased, and VEGF mRNA and protein levels were significantly lower, in placentas from patients with pre-eclampsia (n = 115) compared with placentas from normotensive pregnancies (n = 115). A positive correlation was found between VEGF mRNA and miR-126 expression (r = 0.79). In addition, miR-126 overexpression significantly upregulated VEGF expression in BeWo cells, whereas miR-126 downregulation decreased VEGF expression. CONCLUSIONS:miR-126 was downregulated in placentas from patients with pre-eclampsia and this correlated with decreased VEGF expression. These findings indicate that miRNA-126 may be involved in pre-eclampsia pathogenesis and could be a potential biomarker for this disease.
Authors: Akriti S Sahay; Anjali T Jadhav; Deepali P Sundrani; Girija N Wagh; Savita S Mehendale; Preeti Chavan-Gautam; Sadhana R Joshi Journal: Mol Cell Biochem Date: 2017-08-02 Impact factor: 3.396
Authors: Jeanie B Tryggestad; Anu Vishwanath; Shaoning Jiang; Ashwini Mallappa; April M Teague; Yusuke Takahashi; David M Thompson; Steven D Chernausek Journal: Clin Sci (Lond) Date: 2016-08-25 Impact factor: 6.124
Authors: Laura María Rodríguez Santa; Laura Yuriko González Teshima; Jose Vicente Forero Forero; Andres Orlando Castillo Giraldo Journal: J Pregnancy Date: 2015-10-13
Authors: Carlos A Escudero; Kurt Herlitz; Felipe Troncoso; Jesenia Acurio; Claudio Aguayo; James M Roberts; Grace Truong; Gregory Duncombe; Gregory Rice; Carlos Salomon Journal: Front Physiol Date: 2016-03-18 Impact factor: 4.566